An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury

Juan Piantino, J. A. Burdick, D. Goldberg, R. Langer, L. I. Benowitz

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

The failure of long descending pathways to regenerate after spinal cord injury (SCI) is generally attributed to inhibitory proteins associated with the glial scar and myelin, or to the loss of neurons' intrinsic capacity to grow, or both. Here, we describe the use of hydrogels as a novel way to deliver molecules that promote axon growth in the injured CNS of adult rats. This method utilizes an injectable liquid polymer solution that crosslinks into a biodegradable, water-swollen hydrogel when photoactivated under visible light. Neurotrophin-3 (NT-3), a trophic factor known to act on corticospinal tract (CST) projection neurons, was used as a prototypic pro-regenerative molecule. Hydrogel release properties were established in vitro to ensure long-term, sustained NT-3 release over a 2-week period; this avoided the need for multiple injections or minipump implantation. Hydrogel/NT-3-treated animals showed improved recovery in the open-field BBB test and in a horizontal ladder walk test compared to controls implanted with hydrogel alone. At the anatomical level, hydrogel/NT-3-treated animals showed far greater axon growth than controls in two major descending pathways for motor control, the CST and the raphespinal tract. In the case of the CST, much of the NT-3-induced growth represented collateral branching from undamaged ventral CST fibers. These studies demonstrate the effectiveness of hydrogel technology as a clinically feasible delivery system to promote regeneration and enhance functional outcome after spinal cord injury.

Original languageEnglish (US)
Pages (from-to)359-367
Number of pages9
JournalExperimental Neurology
Volume201
Issue number2
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Hydrogel
Neurotrophin 3
Spinal Cord Injuries
Pyramidal Tracts
Injections
Axons
Growth
Efferent Pathways
Neurons
Hydrogels
Myelin Sheath
Neuroglia
Cicatrix
Regeneration
Polymers
Technology
Light
Water
Proteins

Keywords

  • Axon regeneration
  • Corticospinal
  • Functional recovery
  • Hydrogels
  • Neurotrophins
  • NT-3
  • Plasticity
  • Raphespinal
  • Spinal cord injury

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. / Piantino, Juan; Burdick, J. A.; Goldberg, D.; Langer, R.; Benowitz, L. I.

In: Experimental Neurology, Vol. 201, No. 2, 10.2006, p. 359-367.

Research output: Contribution to journalArticle

@article{abc81d343a414b07b074d4c2fea670c0,
title = "An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury",
abstract = "The failure of long descending pathways to regenerate after spinal cord injury (SCI) is generally attributed to inhibitory proteins associated with the glial scar and myelin, or to the loss of neurons' intrinsic capacity to grow, or both. Here, we describe the use of hydrogels as a novel way to deliver molecules that promote axon growth in the injured CNS of adult rats. This method utilizes an injectable liquid polymer solution that crosslinks into a biodegradable, water-swollen hydrogel when photoactivated under visible light. Neurotrophin-3 (NT-3), a trophic factor known to act on corticospinal tract (CST) projection neurons, was used as a prototypic pro-regenerative molecule. Hydrogel release properties were established in vitro to ensure long-term, sustained NT-3 release over a 2-week period; this avoided the need for multiple injections or minipump implantation. Hydrogel/NT-3-treated animals showed improved recovery in the open-field BBB test and in a horizontal ladder walk test compared to controls implanted with hydrogel alone. At the anatomical level, hydrogel/NT-3-treated animals showed far greater axon growth than controls in two major descending pathways for motor control, the CST and the raphespinal tract. In the case of the CST, much of the NT-3-induced growth represented collateral branching from undamaged ventral CST fibers. These studies demonstrate the effectiveness of hydrogel technology as a clinically feasible delivery system to promote regeneration and enhance functional outcome after spinal cord injury.",
keywords = "Axon regeneration, Corticospinal, Functional recovery, Hydrogels, Neurotrophins, NT-3, Plasticity, Raphespinal, Spinal cord injury",
author = "Juan Piantino and Burdick, {J. A.} and D. Goldberg and R. Langer and Benowitz, {L. I.}",
year = "2006",
month = "10",
doi = "10.1016/j.expneurol.2006.04.020",
language = "English (US)",
volume = "201",
pages = "359--367",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury

AU - Piantino, Juan

AU - Burdick, J. A.

AU - Goldberg, D.

AU - Langer, R.

AU - Benowitz, L. I.

PY - 2006/10

Y1 - 2006/10

N2 - The failure of long descending pathways to regenerate after spinal cord injury (SCI) is generally attributed to inhibitory proteins associated with the glial scar and myelin, or to the loss of neurons' intrinsic capacity to grow, or both. Here, we describe the use of hydrogels as a novel way to deliver molecules that promote axon growth in the injured CNS of adult rats. This method utilizes an injectable liquid polymer solution that crosslinks into a biodegradable, water-swollen hydrogel when photoactivated under visible light. Neurotrophin-3 (NT-3), a trophic factor known to act on corticospinal tract (CST) projection neurons, was used as a prototypic pro-regenerative molecule. Hydrogel release properties were established in vitro to ensure long-term, sustained NT-3 release over a 2-week period; this avoided the need for multiple injections or minipump implantation. Hydrogel/NT-3-treated animals showed improved recovery in the open-field BBB test and in a horizontal ladder walk test compared to controls implanted with hydrogel alone. At the anatomical level, hydrogel/NT-3-treated animals showed far greater axon growth than controls in two major descending pathways for motor control, the CST and the raphespinal tract. In the case of the CST, much of the NT-3-induced growth represented collateral branching from undamaged ventral CST fibers. These studies demonstrate the effectiveness of hydrogel technology as a clinically feasible delivery system to promote regeneration and enhance functional outcome after spinal cord injury.

AB - The failure of long descending pathways to regenerate after spinal cord injury (SCI) is generally attributed to inhibitory proteins associated with the glial scar and myelin, or to the loss of neurons' intrinsic capacity to grow, or both. Here, we describe the use of hydrogels as a novel way to deliver molecules that promote axon growth in the injured CNS of adult rats. This method utilizes an injectable liquid polymer solution that crosslinks into a biodegradable, water-swollen hydrogel when photoactivated under visible light. Neurotrophin-3 (NT-3), a trophic factor known to act on corticospinal tract (CST) projection neurons, was used as a prototypic pro-regenerative molecule. Hydrogel release properties were established in vitro to ensure long-term, sustained NT-3 release over a 2-week period; this avoided the need for multiple injections or minipump implantation. Hydrogel/NT-3-treated animals showed improved recovery in the open-field BBB test and in a horizontal ladder walk test compared to controls implanted with hydrogel alone. At the anatomical level, hydrogel/NT-3-treated animals showed far greater axon growth than controls in two major descending pathways for motor control, the CST and the raphespinal tract. In the case of the CST, much of the NT-3-induced growth represented collateral branching from undamaged ventral CST fibers. These studies demonstrate the effectiveness of hydrogel technology as a clinically feasible delivery system to promote regeneration and enhance functional outcome after spinal cord injury.

KW - Axon regeneration

KW - Corticospinal

KW - Functional recovery

KW - Hydrogels

KW - Neurotrophins

KW - NT-3

KW - Plasticity

KW - Raphespinal

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=33748430801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748430801&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2006.04.020

DO - 10.1016/j.expneurol.2006.04.020

M3 - Article

VL - 201

SP - 359

EP - 367

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -